Malignant ascites after subduroperitoneal shunt in a patient with leptomeningeal metastasis
- PMID: 22200024
- PMCID: PMC3243845
- DOI: 10.3340/jkns.2011.50.4.385
Malignant ascites after subduroperitoneal shunt in a patient with leptomeningeal metastasis
Abstract
Leptomeningeal metastasis is a devastating complication of advanced stage cancer. It is frequently accompanied by hydrocephalus and intracranial hypertension that must be treated by ventriculoperitoneal shunts. However, there are actual risks of peritoneal seeding or accumulation of malignant ascites after the cerebrospinal fluid diversion procedure, though it has not been reported. Here, we present the case of a patient with non-small cell lung cancer with leptomeningeal metastasis in whom malignant ascites developed after a subduroperitoneal shunt.
Keywords: Leptomeningeal metastasis; Malignant ascites; Ventriculoperitoneal shunt.
Figures



References
-
- Chamberlain MC. Leptomeningeal metastases : a review of evaluation and treatment. J Neurooncol. 1998;37:271–284. - PubMed
-
- Coelho Neto M, Ramina R, de Meneses MS, Arruda WO, Milano JB. Peritoneal dissemination from central neurocytoma : case report. Arq Neuropsiquiatr. 2003;61:1030–1034. - PubMed
-
- Eralp Y, Saip P, Aydin Z, Berkman S, Topuz E. Leptomeningeal dissemination of ovarian carcinoma through a ventriculoperitoneal shunt. Gynecol Oncol. 2008;108:248–250. - PubMed
-
- Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L, Swinnen LJ, et al. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res. 1999;5:3394–3402. - PubMed
-
- Herrlinger U, Förschler H, Küker W, Meyermann R, Bamberg M, Dichgans J, et al. Leptomeningeal metastasis : survival and prognostic factors in 155 patients. J Neurol Sci. 2004;223:167–178. - PubMed
Publication types
LinkOut - more resources
Full Text Sources